210 related articles for article (PubMed ID: 2555183)
1. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.
Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S
EMBO J; 1989 Sep; 8(9):2661-8. PubMed ID: 2555183
[TBL] [Abstract][Full Text] [Related]
2. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
[TBL] [Abstract][Full Text] [Related]
3. Myristoylation is important at multiple stages in poliovirus assembly.
Moscufo N; Simons J; Chow M
J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
[TBL] [Abstract][Full Text] [Related]
4. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
[TBL] [Abstract][Full Text] [Related]
5. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
Marc D; Masson G; Girard M; van der Werf S
J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
[TBL] [Abstract][Full Text] [Related]
6. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.
Marc D; Girard M; van der Werf S
J Gen Virol; 1991 May; 72 ( Pt 5)():1151-7. PubMed ID: 1851815
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
Ansardi DC; Morrow CD
J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.
Tesar M; Jia XY; Summers DF; Ehrenfeld E
Virology; 1993 Jun; 194(2):616-26. PubMed ID: 8389076
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
10. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
Ypma-Wong MF; Semler BL
J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
[TBL] [Abstract][Full Text] [Related]
11. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
[TBL] [Abstract][Full Text] [Related]
12. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
Porter DC; Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
Martín-Belmonte F; López-Guerrero JA; Carrasco L; Alonso MA
Biochemistry; 2000 Feb; 39(5):1083-90. PubMed ID: 10653654
[TBL] [Abstract][Full Text] [Related]
14. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
Moscufo N; Chow M
J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
[TBL] [Abstract][Full Text] [Related]
15. Amino acid residue penultimate to the amino-terminal gly residue strongly affects two cotranslational protein modifications, N-myristoylation and N-acetylation.
Utsumi T; Sato M; Nakano K; Takemura D; Iwata H; Ishisaka R
J Biol Chem; 2001 Mar; 276(13):10505-13. PubMed ID: 11124252
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
[TBL] [Abstract][Full Text] [Related]
17. Vertical-scanning mutagenesis of amino acids in a model N-myristoylation motif reveals the major amino-terminal sequence requirements for protein N-myristoylation.
Utsumi T; Nakano K; Funakoshi T; Kayano Y; Nakao S; Sakurai N; Iwata H; Ishisaka R
Eur J Biochem; 2004 Feb; 271(4):863-74. PubMed ID: 14764103
[TBL] [Abstract][Full Text] [Related]
18. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
[TBL] [Abstract][Full Text] [Related]
19. Myristylation of picornavirus capsid protein VP4 and its structural significance.
Chow M; Newman JF; Filman D; Hogle JM; Rowlands DJ; Brown F
Nature; 1987 Jun 11-17; 327(6122):482-6. PubMed ID: 3035380
[TBL] [Abstract][Full Text] [Related]
20. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Göttlinger HG; Sodroski JG; Haseltine WA
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5781-5. PubMed ID: 2788277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]